Identification of candidate responders for anti-PD-L1/PD-1 immunotherapy, Rova-T therapy, or EZH2 inhibitory therapy in small-cell lung cancer
Motonobu Saito(Fukushima Medical University), Akiteru Goto(Akita University)
Cited by 29
Related Papers
Genome structure‐based screening identified epigenetically silenced microRNA associated with invasiveness in non‐small‐cell lung cancer
|International Journal of Cancer|2011|97
MicroRNA-21 in cancer-associated fibroblasts supports lung adenocarcinoma progression
|Scientific Reports|2018|78
Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition
|Human Pathology|2014|76
High-grade Lung Adenocarcinoma With Fetal Lung–like Morphology
|The American Journal of Surgical Pathology|2013|74